Brunei vs Sweden: Cause of death, by non-communicable diseases, ages 60+, male
Brunei
83.4%
in 2021
Sweden
83.8%
in 2021
Brunei rank
23rd
Sweden rank
20th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Brunei
- Sweden
How they compare
Sweden currently reports 83.8% against 83.4% in Brunei, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Sweden ahead.
Brunei ranks 23rd and Sweden ranks 20th of 185 countries.
Across the 3 decades both report, Brunei averaged higher in 1 and Sweden in 2.
Head to head by decade
| Decade | Brunei | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.5% | 91.5% | 1.0% | Sweden |
| 2010s | 86.2% | 90.5% | 4.2% | Sweden |
| 2020s | 84.9% | 82.2% | 2.8% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Brunei or Sweden?
- Sweden, at 83.8% against 83.4% in Brunei as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Brunei and Sweden?
- 0.4%, with Sweden ahead.
- How many years of comparable data are there for Brunei and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Sweden rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Brunei ranks 23rd and Sweden ranks 20th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.